-transparent.png){kind=logo}
A variety of options are available for the medical treatment of peptic ulcer disease, including antacids, histamine2 receptor antagonists, omeprazole, prostaglandin analogues, and sucralfate and bismuth formulations. Seventy percent to 90% of peptic duodenal and gastric ulcers will heal after 4 to 8 weeks of therapy. Combination regimens using these agents have not been demonstrated to be superior to single-agent therapy. Aggressive acid suppression with "high-dose" histamine2 receptor antagonists or omeprazole accelerates healing of ordinary ulcers and promotes healing of previously refractory ulcers. Although ulcer recurrence is diminished by continuous "maintenance" therapy with the aforementioned agents, recurrence seems to be dramatically suppressed after eradication of Helicobacter pylori from the gastroduodenal mucosa.
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
February 2004,
Fundamental & clinical pharmacology,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
May 1990,
Vrachebnoe delo,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
August 1985,
Vrachebnoe delo,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
January 1971,
Modern trends in surgery,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
December 1971,
Zentralblatt fur Chirurgie,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
January 1997,
Indian journal of physiology and pharmacology,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
April 1960,
Military medicine,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
July 1964,
Northwest medicine,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
September 1985,
Polskie Archiwum Medycyny Wewnetrznej,
L J Hixson, and
C L Kelley, and
W N Jones, and
C D Tuohy
March 1979,
Southern medical journal,
